Björn E. E. Wahlin

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: BLOOD CANCER JOURNAL. 2021;11(1):9
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
Harrysson S; Eloranta S; Ekberg S; Enblad G; Jerkeman M; Wahlin BE; Andersson P-O; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(1):75-81
Survival of very elderly patients with diffuse large B-cell lymphoma according to treatment intensity in the immunochemotherapy era: a Swedish Lymphoma Register study
Sonnevi K; Wasterlid T; Melen CM; Harrysson S; Smedby KE; Wahlin BE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;191(5):738-747
The simplified follicular lymphoma PRIMA-prognostic index is useful in patients with first-line chemo-free rituximab-based therapy
Kimby E; Lockmer S; Holte H; Hagberg H; Wahlin BE; Brown P; Ostenstad B
Article: BLOOD. 2020;136(18):2038-2050
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenstrom macroglobulinemia: the ASPEN study
Tam CS; Opat S; D'Sa S; Jurczak W; Lee H-P; Cull G; Owen RG; Marlton P; Wahlin BE; Garcia Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyz J; Fernandez de Larrea C; Belada D; Libby E; Matous JV; Motta M; Siddiqi T; Tani M; Trneny M; Minnema MC; Buske C; Leblond V; Trotman J; Chan WY; Schneider J; Ro S; Cohen A; Huang J; Dimopoulos M
Article: ANNALS OF HEMATOLOGY. 2020;99(10):2357-2366
Absolute B cell counts in blood predict long-term response in follicular lymphoma patients treated with rituximab without chemotherapy
Junlen H-R; Lockmer S; Kimby E; Wahlin BE
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2020;183(4):453-462
Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort study.
Majidi F; Martino S; Kondakci M; Antke C; Haase M; Chortis V; Arlt W; Ronchi CL; Fassnacht M; Laurent C; Petit J-M; Casasnovas O; Habra MA; Kanji A; Salvatori R; Ho ATN; Spyroglou A; Beuschlein F; Villa D; Limvorapitak W; Wahlin BE; Gimm O; Rudelius M; Schott M; Germing U; Haas R; Gattermann N
Article: BONE MARROW TRANSPLANTATION. 2020;55(4):796-803
Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT.
Domingo-Domènech E; Boumendil A; Climent F; Sengeloev H; Wahlin B; Wattad W; Arat M; Finel H; Schapp N; Ganser A; Yeshurun M; Pavone V; Snowden J; Finke J; Montoto S; Sureda A; Dreger P; Lymphoma Working Party of the European Society for
Article: BONE MARROW TRANSPLANTATION. 2020;55(3):613-622
Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor
Sureda A; Chabannon C; Masszi T; Pohlreich D; Scheid C; Thieblemont C; Wahlin BE; Sakellari I; Russell N; Janikova A; Dabrowska-Iwanicka A; Touzeau C; Esquirol A; Jantunen E; van der Werf S; Bosman P; Boumendil A; Liu Q; Celanovic M; Montoto S; Dreger P
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;188(2):259-267
M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy
Lockmer S; Ren W; Brodtkorb M; Ostenstad B; Wahlin BE; Pan-Hammarstrom Q; Kimby E
Article: BLOOD. 2019;134(4):353-362
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy
Zucca E; Rondeau S; Vanazzi A; Ostenstad B; Mey UJM; Rauch D; Wahlin BE; Hitz F; Hernberg M; Johansson A-S; Brown PDN; Hagberg H; Ferreri AJM; Lohri A; Novak U; Zander T; Bersvendsen H; Bargetzi M; Mingrone W; Krasniqi F; Dirnhofer S; Hayoz S; Hawle H; Vilei SB; Ghielmini M; Kimby E; Caspar C; Koberle D; Novak U; Zenhausern R; Jost LM; Mach N; Voegeli M; Tscherry G; Fischer N; Burkhard R; Schmid M; Panagiotis S; Munksgaard L; Hernberg M; Vasala K; Lehtinen T; Jyrkkio S; Ekanger R; Rolke J; Meyer P; Maisenholder M; Eidem M; Radlund A; Lagerlof I; Brandefors L; Ola LPN; Arnljots K; Kimby E; Strandberg M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2019;185(4):708-712
Expression of GNAZ, encoding the Gα_z protein, predicts survival in mantle cell lymphoma
Mundt F; Merrien M; Nygren L; Sutton LA; Christensson B; Wahlin BE; Rosenquist R; Sander B; Wasik AM
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:2085
Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma
Enqvist M; Jacobs B; Junlen HR; Schaffer M; Melen CM; Friberg D; Wahlin BE; Malmberg K-J
Article: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2019;8:7
The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994-2016
Carlsten M; Jadersten M; Hellstrom A; Littmann K; Melen CM; Junlen HR; Sonnevi K; Ljungman P; Bjorkstrand B; Wahlin BE
Article: JOURNAL OF CLINICAL ONCOLOGY. 2018;36(33):JCO1800262-3323
Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up
Lockmer S; Ostenstad B; Hagberg H; Holte H; Johansson A-S; Wahlin BE; Wader KF; Steen CB; Meyer P; Maisenholder M; Smedby KE; Brown P; Kimby E
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2018;182(6):807-815
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO
Avivi I; Arcaini L; Ferretti VV; Boumendil A; Finel H; Milone G; Zaja F; Liliana D; Musso M; Didier B; Bachy E; Wattad M; Nicolas-Virelizier E; Gramatzki M; Bourhis J-H; Caillot D; Haenel A; Held G; Thieblemont C; Jindra P; Pohlreich D; Guilhot F; Kroschinsky F; Wahlin B; Scheid C; Ifrah N; Berthou C; Dreger P; Montoto S; Conconi A
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2018;93(8):1020-1028
Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma
Ekberg S; Jerkeman M; Andersson P-O; Enblad G; Wahlin BE; Hasselblom S; Andersson TM; Eloranta S; Smedby KE
Article: CLINICAL CANCER RESEARCH. 2018;24(8):1834-1844
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
Bjorklund AT; Carlsten M; Sohlberg E; Liu LL; Clancy T; Karimi M; Cooley S; Miller JS; Klimkowska M; Schaffer M; Watz E; Wikstrom K; Blomberg P; Wahlin BE; Palma M; Hansson L; Ljungman P; Hellstrom-Lindberg E; Ljunggren H-G; Malmberg K-J
Article: JOURNAL OF CLINICAL APHERESIS. 2017;32(6):384-391
G-CSF mobilized peripheral blood stem cell collection for allogeneic transplantation in healthy donors: Analysis of factors affecting yield
Machaczka M; Hagglund H; Staver E; Joks M; Hassan M; Wahlin BE; Nygell UA
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2017;177(3):449-456
Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: an analysis of the Swedish Lymphoma Registry
Molin D; Linderoth J; Wahlin BE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2016;175(4):614-622
Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study
Melen CM; Enblad G; Sonnevi K; Junlen HR; Smedby KE; Jerkeman M; Wahlin BE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2016;175(1):102-114
The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era
Blaker YN; Spetalen S; Brodtkorb M; Lingjaerde OC; Beiske K; Ostenstad B; Sander B; Wahlin BE; Melen CM; Myklebust JH; Holte H; Delabie J; Smeland EB
Article: LEUKEMIA & LYMPHOMA. 2015;56(9):2598-2607
Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas
Kimby E; Ostenstad B; Brown P; Hagberg H; Erlanson M; Holte H; Linden O; Johansson A-S; Ahlgren T; Wader K; Wahlin BE; Delabie J; Sundstrom C
Article: LEUKEMIA. 2015;29(3):668-676
Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study
Junlen HR; Peterson S; Kimby E; Lockmer S; Linden O; Nilsson-Ehle H; Erlanson M; Hagberg H; Radlund A; Hagberg O; Wahlin BE
Article: SCIENTIFIC REPORTS. 2015;5:7920
Fecal calprotectin as a biomarker of intestinal graft versus host disease after allogeneic hematopoietic stem cell transplantation
Lorenz F; Marklund S; Werner M; Palmqvist R; Wahlin BE; Wahlin A
Article: CLINICAL CANCER RESEARCH. 2014;20(23):6096-6104
T-Cell Levels Are Prognostic in Mantle Cell Lymphoma
Nygren L; Wasik AM; Baumgartner-Wennerholm S; Jeppsson-Ahlberg A; Klimkowska M; Andersson P; Buhrkuhl D; Christensson B; Kimby E; Wahlin BE; Sander B
Article: ONCOSCIENCE. 2014;1(8):550-557
Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features.
Wasik AM; Nygren L; Almestrand S; Zong F; Flygare J; Wennerholm SB; Saft L; Andersson P; Kimby E; Wahlin BE; Christensson B; Sander B
Article: POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ. 2014;124(11):587-592
Clinical utility of different bone marrow examination methods in the diagnosis of adults with sporadic Gaucher disease type 1
Machaczka M; Markuszewska-Kuczynska A; Regenthal S; Jurczyszyn A; Galazka K; Wahlin BE; Klimkowska M
Article: HAEMATOLOGICA. 2014;99(4):715-725
The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium
Sander B; de Jong D; Rosenwald A; Xie W; Balague O; Calaminici M; Carreras J; Gaulard P; Gribben J; Hagenbeek A; Kersten MJ; Molina TJ; Lee A; Montes-Moreno S; Ott G; Raemaekers J; Salles G; Sehn L; Thorns C; Wahlin BE; Gascoyne RD; Weller E
Article: LEUKEMIA & LYMPHOMA. 2014;55(2):288-295
Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy
Wahlin BE; Sundstrom C; Sander B; Christensson B; Jeppsson-Ahlberg A; Hjalmarsson E; Holte H; Ostenstad B; Brown PD; Smeland EB; Kimby E
Article: MEDICAL ONCOLOGY. 2013;30(4):762
High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse
Machaczka M; Johansson J-E; Remberger M; Hallbook H; Lazarevic VL; Wahlin BE; Omar H; Wahlin A; Juliusson G; Kimby E; Hagglund H
Article: MEDICAL ONCOLOGY. 2012;29(3):2070-2076
Association between P-glycoprotein and lymphoid antigen expression on myeloblasts versus therapy response and survival in de novo acute myeloid leukemia: long-term follow-up results
Machaczka M; Wahlin BE; Piatkowska-Jakubas B; Rucinska M; Jurczak W; Balana-Nowak A; Klimkowska M; Hagglund H; Skotnicki AB
Article: MEDICAL ONCOLOGY. 2012;29(3):2191-2199
Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery
Ungerstedt JS; Watz E; Uttervall K; Johansson B-M; Wahlin BE; Nasman P; Ljungman P; Gruber A; Nygell UA; Nahi H
Article: BLOOD CANCER JOURNAL. 2012;2(1):e52
Entourage: the immune microenvironment following follicular lymphoma
Wahlin BE; Sander B; Christensson B; Ostenstad B; Holte H; Brown PD; Sundstrom C; Kimby E
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2012;156(2):225-233
Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times
Wahlin BE; Yri OE; Kimby E; Holte H; Delabie J; Smeland EB; Sundstrom C; Christensson B; Sander B
Article: CLINICAL CANCER RESEARCH. 2011;17(12):4136-4144
T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab
Wahlin BE; Sundstrom C; Holte H; Hagberg H; Erlanson M; Nilsson-Ehle H; Linden O; Nordstrom M; Ostenstad B; Geisler CH; Brown PDN; Lehtinen T; Maisenholder M; Tierens AM; Sander B; Christensson B; Kimby E
Article: MEDICAL ONCOLOGY. 2011;28(2):552-558
Hyperferritinemia is associated with low incidence of graft versus host disease, high relapse rate, and impaired survival in patients with blood disorders receiving allogeneic hematopoietic stem cell grafts
Wahlin A; Lorenz F; Fredriksson M; Remberger M; Wahlin BE; Hagglund H
Article: CLINICAL CANCER RESEARCH. 2010;16(2):637-650
A Unifying Microenvironment Model in Follicular Lymphoma: Outcome Is Predicted by Programmed Death-1-Positive, Regulatory, Cytotoxic, and Helper T Cells and Macrophages
Wahlin BE; Aggarwal M; Montes-Moreno S; Francisco Gonzalez L; Roncador G; Sanchez-Verde L; Christensson B; Sander B; Kimby E
Article: CLINICAL CANCER RESEARCH. 2007;13(2):388-397
CD8+T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma
Wahlin BE; Sander B; Christensson B; Kimby E
Visa fler

Alla övriga publikationer

Letter: LEUKEMIA & LYMPHOMA. 2019;60(13):3316-3319
Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in TET2, DNMT3 and CUX1 - azacitidine induces only lymphoma remission
Tobiasson M; Pandzic T; Cavelier L; Sander B; Wahlin BE
Letter: HAEMATOLOGICA. 2019;104(10):e460-e464
A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy
Steen CB; Leich E; Myklebust JH; Lockmer S; Wise JF; Wahlin BE; Ostenstad B; Liestol K; Kimby E; Rosenwald A; Smeland EB; Holte H; Lingjaerde OC; Brodtkorb M
Review: CANCERS. 2019;11(7):E915-915
Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application
Mulder TA; Wahlin BE; Osterborg A; Palma M
Letter: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(9):759-760
Is Longer Progression-Free Survival a Goal Worth Pursuing in Follicular Lymphoma? Reply
Lockmer S; Ostenstad B; Hagberg H; Holte H; Wahlin BE; Wader KF; Smedby KE; Brown P; Kimby E
Letter: ANNALS OF ONCOLOGY. 2018;29(8):1882-1883
Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study
Wasterlid T; Biccler JL; Brown PN; Bogsted M; Enblad G; Jorgensen JM; Christensen JH; Wahlin BE; Smedby KE; El-Galaly TC; Jerkeman M
Thesis / dissertation: 2011
Prognostic information from nonmalignant and malignant lymphocytes in follicular lymphoma in relation to therapy
Wahlin, Björn Engelbrekt
Meeting abstract: BLOOD. 2004;104(11):889A
T-cells present in tumour tissue may affect the outcome of follicular lymphoma
Wahlin BE; Kimby E; Sander B; Christensson B

Anställningar

Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2023-2026

Examina och utbildning

Docent, hematologi, Karolinska Institutet, 2017
Medicine Doktorsexamen, Institutionen för medicin, Huddinge, Karolinska Institutet, 2011

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI